582 Companies
Checkpoint Therapeutics, Inc., a subsidiary of Fortress Biotech, Inc., has made significant strides in the acquisition, development, and commercialization of novel treatments for solid tumor cancer...
Checkpoint Therapeutics, Inc. Annual Report 20234basebio PLC, a gene therapy company, is aiming to revolutionize the field’s technology and solutions. Their primary focus has been to create synthetic DNA, which offers numerous benefits such as h...
4basebio PLC Annual Report 2023ARCA Biopharma Inc., a clinical development stage biopharmaceutical company, is actively engaged in the development and commercialization of genetically targeted therapies for cardiovascular diseas...
ARCA biopharma, Inc. Annual Report 2022Karuna Therapeutics, Inc. is making waves in the field of clinical-stage biopharmaceuticals, with a focus on delivering transformative medicines to those living with psychiatric and neurological co...
Karuna Therapeutics Annual Report 2022Recro Pharma is a specialty pharmaceutical company that generates revenue by selling products to hospitals and ambulatory care settings. The company is primarily focused on developing non-opioid pr...
Recro Pharma Annual Report 2019Precision BioSciences Inc., a clinical-stage gene editing company based in Durham, North Carolina, has announced its focus on the development of ex vivo allogeneic chimeric antigen receptor (CAR) T...
Precision BioSciences, Inc. Annual Report 2023Enochian Biosciences, Inc., a biotechnology firm in the pre-clinical stage, has been actively involved in developing biological and pharmaceutical products primarily aimed at combating Human Immuno...
Enochian Biosciences, Inc. Annual Report 2023Bionomics Limited, based in Australia, is a company that focuses on the research and development of therapeutics for cancer and diseases of the central nervous system. Their portfolio includes prog...
Bionomics Ltd Annual Report 2023Patrys Limited, an Australian company, develops and commercializes antibody technologies for the treatment of cancer. Its lead technology, Deoxymab 3E10, is a DNA damage-repair antibody that inhibi...
Patrys Limited Annual Report 2023Gene editing company CRISPR Therapeutics AG is making significant strides in the development of gene-based medicines for a wide range of serious diseases by leveraging its highly innovative Cluster...
CRISPR Annual Report 2023NewMarket Corporation (NEU), a leading manufacturer and seller of petroleum additives, is continuing its growth trajectory by expanding its product offerings. The company's subsidiaries create lubr...
NewMarket Annual Report 2023Adaptive Biotechnologies Corporation, a leading commercial-stage biotech firm, has made strides in developing an advanced immune medicine platform to aid in the diagnosis and treatment of diseases....
Adaptive Biotechnologies Annual Report 2023Cambridge-based precision therapy company, Blueprint Medicines Corporation, is making strides in the development of genomic medicines for a variety of cancers and blood disorders. Its portfolio inc...
Blueprint Medicines Annual Report 2023Chapel Hill-based biopharmaceutical company, Tenax Therapeutics, Inc., has announced the development and commercialization of pharmaceutical products that include imatinib for the treatment of pulm...
Tenax Therapeutics, Inc. Annual Report 2023Catabasis Pharmaceuticals is a company committed to finding innovative therapies to improve the lives of patients suffering from Duchenne muscular dystrophy. The company's lead program, edasalonexe...
Catabasis Pharmaceuticals, Inc. Annual Report 2019